nonresponse

Moreover presence of insulin resistance and diabetes are risk factors for fibrosis progression and nonresponse to antiviral therapy in chronic hepatitis C (CHC).

此外，胰岛素抵和糖尿病是慢性丙型肝炎（CHC）中纤维化进展病毒治疗无应的危险因素。